栓塞对髂腰肌血肿结局影响的多中心倾向匹配研究
本研究纳入两中心CT确诊髂腰肌血肿伴活动性动脉出血患者146例,评估栓塞对30天死亡率的影响。结果显示保守治疗、栓塞与手术三组30天死亡率分别为29%、27%、26%,差异无统计学意义。栓塞未改善30天生存,但CT至栓塞延迟≥3小时与抗凝逆转治疗独立关联更高死亡率,提示若选择栓塞应尽快实施。
要点
- 髂腰肌血肿伴活动性出血者,栓塞未显示改善30天生存,报告结论不宜过度支持栓塞。
- CT发现活动性出血后若拟行栓塞,间隔≥3小时与30天死亡率升高独立相关。
- 需抗凝逆转治疗的患者死亡风险升高,阅片提示活动性出血时应及时与临床沟通。
核心结论
- 该多中心队列中,栓塞未改善髂腰肌血肿患者30天生存。
- 在接受栓塞的患者中,CT至栓塞间隔较短与更好结局相关,提示若选择栓塞应尽快实施。
- CT至栓塞延迟≥3小时是30天死亡率升高的独立危险因素。
研究设计与样本
- 采用倾向评分匹配和Cox回归分析评估栓塞对30天死亡率的影响。
关键影像表现/征象
- 所有纳入患者均经CT确认髂腰肌血肿并存在活动性动脉出血。
诊断标准与关键数值
- 30天总体死亡率为27%(40/146)。
- 保守治疗组死亡率为29%(15/51),栓塞组为27%(14/52),手术组为26%(11/43),组间差异P=0.84。
- 倾向评分匹配前后30天死亡率均无显著性差异。
- 多变量分析中,CT与栓塞间隔≥3小时的风险比为8.69(95%CI 1.02-72.24,P=0.046)。
- 抗凝逆转治疗给药的风险比为4.69(95%CI 1.03-21.39,P=0.047)。
临床应用与阅片要点
- 放射科医生在CT发现髂腰肌血肿伴活动性出血时,应及时提示临床并记录出血征象时间节点。
- 对拟行介入栓塞者,CT诊断至栓塞的间隔应尽量缩短在3小时以内。
- 阅片报告中应关注患者是否接受抗凝治疗及可能需要的抗凝逆转治疗。
局限性
- 回顾性多中心研究设计。
- 两中心纳入时间范围不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The role of embolization in iliopsoas hematoma (IPH) remains unclear, and there are no specific guidelines regarding the optimal timing of this procedure. This study aimed to assess the effect of embolization on 30-day mortality in patients with IPH.
MATERIALS AND METHODS: This retrospective multicenter study included patients with Computed Tomography (CT)-confirmed IPH and active arterial bleeding between January 2017 and December 2023 in the first center and between January 2015 and July 2020 in the second center. Clinical, biological, imaging and procedural data were retrospectively collected. Embolization was performed by interventional radiologists, and procedural details were recorded. The effect of embolization on 30-day mortality was assessed using propensity score matching and Cox regression analyses.
RESULTS: A total of 146 patients with CT-confirmed IPH and active bleeding were included. The 30-day mortality rate was 40/146 (27%). Mortality rates were 15/51 (29%), 14/52 (27%), and 11/43 (26%) for conservative management, embolization, and surgery, respectively (P = 0.84). No significant difference in 30-day mortality was observed before or after propensity score matching. In multivariable analysis, a delay ≥ 3 h between CT and embolization and anticoagulation reversal therapy administration were independently associated with higher 30-day mortality (hazard ratio [HR], 8.69; 95% CI, 1.02-72.24; P = 0.046 and HR, 4.69; 95% CI, 1.03-21.39; P = 0.047, respectively).
CONCLUSION: In this multicenter cohort, embolization did not improve 30-day survival. However, among embolized patients, shorter CT-to-embolization delays were associated with better outcomes, suggesting that when embolization is chosen, it should be performed promptly.
引用
- Moinet, Moyne, Simon, et al. Evaluating the Impact of Embolization on Outcomes in Iliopsoas Hematomas: A Multicenter Retrospective Propensity-matched Study. Acad Radiol. 2026. PMID: 42386455. doi:10.1016/j.acra.2026.06.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。